<i>DPYD</i> -Guided Dosing of Metronomic Capecitabine Plus Vinorelbine in Metastatic Human Epidermal Growth Factor Receptor 2–Negative Breast Cancer: A Real-World Retrospective Study
Francesco Schettini(Target (United States)), Daniele Generali(Istituti Ospitalieri di Cremona), Aldo Caltavituro(University of Naples Federico II), G Grazia(Breast Cancer Research Foundation), Marta Gatti(Istituti Ospitalieri di Cremona), S. Tedoldi(Istituti Ospitalieri di Cremona), Sergio Venturini(University of Turin), Leda Paganini(Istituti Ospitalieri di Cremona), Carla Strina(Istituti Ospitalieri di Cremona), Alexandro Membrino(Istituti Ospitalieri di Cremona), Marzia Alberio(Istituti Ospitalieri di Cremona), Manuela Milani(Humanitas University), Mario Giuliano(University of Naples Federico II), Antonina Impeduglia(Istituti Ospitalieri di Cremona), Valeria Cervoni(University of Trieste), Anna Bosi(Istituti Ospitalieri di Cremona)
Cited by 0
Related Papers
The Role of ATF4 Stabilization and Autophagy in Resistance of Breast Cancer Cells Treated with Bortezomib
|Cancer Research|2009|298
Hypoxia-Inducible Factor-1α Expression Predicts a Poor Response to Primary Chemoendocrine Therapy and Disease-Free Survival in Primary Human Breast Cancer
|Clinical Cancer Research|2006|244
Effects of Acute versus Chronic Hypoxia on DNA Damage Responses and Genomic Instability
|Cancer Research|2010|205
CDK 4/6 Inhibitors as Single Agent in Advanced Solid Tumors
|Frontiers in Oncology|2018|205
Role of ATF4 in regulation of autophagy and resistance to drugs and hypoxia
|Cell Cycle|2009|197